Closing the Gap in Cancer Genomic Testing
- 8 December 2022
- journal article
- editorial
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 387 (23), 2107-2110
- https://doi.org/10.1056/nejmp2210638
Abstract
Genomic analysis of tumor tissue and circulating tumor DNA is an increasingly important component of cancer care. But evidence indicates underutilization of tumor genomic testing.Keywords
This publication has 3 references indexed in Scilit:
- Impact of a Clinical Genomics Program on Trial Accrual for Targeted Treatments: Practical Approach Overcoming Barriers to Accrual for Underserved PatientsJCO Clinical Cancer Informatics, 2022
- Implementing Precision Medicine in Community-Based Oncology Programs: Three ModelsJournal of Oncology Practice, 2019
- The current state of molecular testing in the treatment of patients with solid tumors, 2019CA: A Cancer Journal for Clinicians, 2019